 | • レポートコード：D005-11326 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、核医学/放射性医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。核医学/放射性医薬品の種類別市場規模（Tc-99、I-123 / 131、In-111、Xe-133、Th-201、Ga-67、その他）、用途別市場規模（診断、治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GE Healthcare、Eli Lilly、Lantheus Medical Imaging、Bracco Imaging、Nordion、Mallinckrodt、China Isotope & Radiation、Jubilant Pharma、Bayer、SIEMENS、Yantai Dongcheng Biochemicals ・地域別グローバル市場分析 2015年-2020年 ・核医学/放射性医薬品の北米市場（アメリカ、カナダ、メキシコ） ・核医学/放射性医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・核医学/放射性医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・核医学/放射性医薬品の南米市場（ブラジル、アルゼンチン） ・核医学/放射性医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：Tc-99、I-123 / 131、In-111、Xe-133、Th-201、Ga-67、その他 ・用途別分析：診断、治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Nuclear Medicine/Radiopharmaceutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nuclear Medicine/Radiopharmaceutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nuclear Medicine/Radiopharmaceutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nuclear Medicine/Radiopharmaceutic market has been segmented into
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
By Application, Nuclear Medicine/Radiopharmaceutic has been segmented into:
Diagnostic
Therapeutic
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine/Radiopharmaceutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine/Radiopharmaceutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine/Radiopharmaceutic market.
The report offers in-depth assessment of the growth and other aspects of the Nuclear Medicine/Radiopharmaceutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nuclear Medicine/Radiopharmaceutic Market Share Analysis
Nuclear Medicine/Radiopharmaceutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Medicine/Radiopharmaceutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine/Radiopharmaceutic sales, revenue and market share for each player covered in this report.
The major players covered in Nuclear Medicine/Radiopharmaceutic are:
GE Healthcare
Eli Lilly
Lantheus Medical Imaging
Bracco Imaging
Nordion
Mallinckrodt
China Isotope & Radiation
Jubilant Pharma
Bayer
SIEMENS
Yantai Dongcheng Biochemicals
Among other players domestic and global, Nuclear Medicine/Radiopharmaceutic market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Medicine/Radiopharmaceutic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Medicine/Radiopharmaceutic, with price, sales, revenue and global market share of Nuclear Medicine/Radiopharmaceutic in 2018 and 2019.
Chapter 3, the Nuclear Medicine/Radiopharmaceutic competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Medicine/Radiopharmaceutic breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nuclear Medicine/Radiopharmaceutic market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nuclear Medicine/Radiopharmaceutic sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nuclear Medicine/Radiopharmaceutic Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Medicine/Radiopharmaceutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Medicine/Radiopharmaceutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Overview of Global Nuclear Medicine/Radiopharmaceutic Market
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GE Healthcare
2.1.1 GE Healthcare Details
2.1.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GE Healthcare SWOT Analysis
2.1.4 GE Healthcare Product and Services
2.1.5 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly SWOT Analysis
2.2.4 Eli Lilly Product and Services
2.2.5 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Lantheus Medical Imaging
2.3.1 Lantheus Medical Imaging Details
2.3.2 Lantheus Medical Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Lantheus Medical Imaging SWOT Analysis
2.3.4 Lantheus Medical Imaging Product and Services
2.3.5 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bracco Imaging
2.4.1 Bracco Imaging Details
2.4.2 Bracco Imaging Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bracco Imaging SWOT Analysis
2.4.4 Bracco Imaging Product and Services
2.4.5 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nordion
2.5.1 Nordion Details
2.5.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Nordion SWOT Analysis
2.5.4 Nordion Product and Services
2.5.5 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mallinckrodt
2.6.1 Mallinckrodt Details
2.6.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Mallinckrodt SWOT Analysis
2.6.4 Mallinckrodt Product and Services
2.6.5 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 China Isotope & Radiation
2.7.1 China Isotope & Radiation Details
2.7.2 China Isotope & Radiation Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 China Isotope & Radiation SWOT Analysis
2.7.4 China Isotope & Radiation Product and Services
2.7.5 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Jubilant Pharma
2.8.1 Jubilant Pharma Details
2.8.2 Jubilant Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Jubilant Pharma SWOT Analysis
2.8.4 Jubilant Pharma Product and Services
2.8.5 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 SIEMENS
2.10.1 SIEMENS Details
2.10.2 SIEMENS Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 SIEMENS SWOT Analysis
2.10.4 SIEMENS Product and Services
2.10.5 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Yantai Dongcheng Biochemicals
2.11.1 Yantai Dongcheng Biochemicals Details
2.11.2 Yantai Dongcheng Biochemicals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Yantai Dongcheng Biochemicals SWOT Analysis
2.11.4 Yantai Dongcheng Biochemicals Product and Services
2.11.5 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share in 2019
3.3.2 Top 6 Nuclear Medicine/Radiopharmaceutic Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Regions (2015-2020)
4.2 North America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
4.3 Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
4.5 South America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
5.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
5.2 United States Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
5.3 Canada Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
5.4 Mexico Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
6.2 Germany Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
6.3 UK Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
6.4 France Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
6.5 Russia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
6.6 Italy Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Regions (2015-2020)
7.2 China Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
7.3 Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
7.4 Korea Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
7.5 India Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
7.7 Australia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
8.1.2 South America Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
8.3 Argentina Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
9.3 Turkey Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
9.5 South Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2015-2020)
10.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2015-2020)
10.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2015-2020)
11 Global Nuclear Medicine/Radiopharmaceutic Market Segment by Application
11.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2015-2020)
11.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2015-2020)
11.3 Global Nuclear Medicine/Radiopharmaceutic Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Growth Rate (2021-2025)
12.2 Nuclear Medicine/Radiopharmaceutic Market Forecast by Regions (2021-2025)
12.2.1 North America Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
12.2.2 Europe Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
12.2.4 South America Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025)
12.3 Nuclear Medicine/Radiopharmaceutic Market Forecast by Type (2021-2025)
12.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2025)
12.3.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Type (2021-2025)
12.4 Nuclear Medicine/Radiopharmaceutic Market Forecast by Application (2021-2025)
12.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2025)
12.4.2 Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nuclear Medicine/Radiopharmaceutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Medicine/Radiopharmaceutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. GE Healthcare Nuclear Medicine/Radiopharmaceutic Major Business
Table 9. GE Healthcare Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 10. GE Healthcare SWOT Analysis
Table 11. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product and Services
Table 12. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly Nuclear Medicine/Radiopharmaceutic Major Business
Table 15. Eli Lilly Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 16. Eli Lilly SWOT Analysis
Table 17. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product and Services
Table 18. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 20. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Major Business
Table 21. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 22. Lantheus Medical Imaging SWOT Analysis
Table 23. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product and Services
Table 24. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 26. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Major Business
Table 27. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 28. Bracco Imaging SWOT Analysis
Table 29. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product and Services
Table 30. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Nordion Basic Information, Manufacturing Base and Competitors
Table 32. Nordion Nuclear Medicine/Radiopharmaceutic Major Business
Table 33. Nordion Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 34. Nordion SWOT Analysis
Table 35. Nordion Nuclear Medicine/Radiopharmaceutic Product and Services
Table 36. Nordion Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 38. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Major Business
Table 39. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 40. Mallinckrodt SWOT Analysis
Table 41. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product and Services
Table 42. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 44. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Major Business
Table 45. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 46. China Isotope & Radiation SWOT Analysis
Table 47. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product and Services
Table 48. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 50. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Major Business
Table 51. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 52. Jubilant Pharma SWOT Analysis
Table 53. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product and Services
Table 54. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bayer Basic Information, Manufacturing Base and Competitors
Table 56. Bayer Nuclear Medicine/Radiopharmaceutic Major Business
Table 57. Bayer Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 58. Bayer SWOT Analysis
Table 59. Bayer Nuclear Medicine/Radiopharmaceutic Product and Services
Table 60. Bayer Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 62. SIEMENS Nuclear Medicine/Radiopharmaceutic Major Business
Table 63. SIEMENS Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 64. SIEMENS SWOT Analysis
Table 65. SIEMENS Nuclear Medicine/Radiopharmaceutic Product and Services
Table 66. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Yantai Dongcheng Biochemicals Basic Information, Manufacturing Base and Competitors
Table 68. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Major Business
Table 69. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Total Revenue (USD Million) (2018-2019)
Table 70. Yantai Dongcheng Biochemicals SWOT Analysis
Table 71. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product and Services
Table 72. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturer (2018-2019) (K MT)
Table 74. Global Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Nuclear Medicine/Radiopharmaceutic Sales by Regions (2015-2020) (K MT)
Table 76. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions (2015-2020)
Table 77. Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2015-2020) (K MT)
Table 79. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2015-2020)
Table 80. North America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2015-2020)
Table 82. Europe Nuclear Medicine/Radiopharmaceutic Sales by Countries (2015-2020) (K MT)
Table 83. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2015-2020)
Table 84. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales by Regions (2015-2020) (K MT)
Table 86. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Nuclear Medicine/Radiopharmaceutic Sales by Countries (2015-2020) (K MT)
Table 89. South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2015-2020)
Table 90. South America Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Countries (2015-2020) (K MT)
Table 93. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2015-2020)
Table 96. Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2015-2020) (K MT)
Table 97. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2015-2020)
Table 98. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2015-2020) (USD Million)
Table 99. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2015-2020)
Table 100. Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2015-2020) (K MT)
Table 101. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2015-2020)
Table 102. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Regions (2021-2025) (K MT)
Table 103. Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Regions (2021-2025)
Table 104. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2021-2025) (K MT)
Table 105. Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Type (2021-2025)
Table 106. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2021-2025)
Table 107. Global Nuclear Medicine/Radiopharmaceutic Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Picture
Figure 2. Global Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type in 2019
Figure 3. Tc-99 Picture
Figure 4. I-123/131 Picture
Figure 5. In-111 Picture
Figure 6. Xe-133 Picture
Figure 7. Th-201 Picture
Figure 8. Ga-67 Picture
Figure 9. Other Picture
Figure 10. Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2018
Figure 11. Diagnostic Picture
Figure 12. Therapeutic Picture
Figure 13. Global Nuclear Medicine/Radiopharmaceutic Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturer in 2019
Figure 34. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Nuclear Medicine/Radiopharmaceutic Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 39. Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions (2015-2020)
Figure 41. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions in 2018
Figure 42. North America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
Figure 43. Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
Figure 45. South America Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020)
Figure 47. North America Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries (2015-2020)
Figure 49. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2018
Figure 50. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2018
Figure 52. United States Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Canada Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Mexico Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Europe Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2019
Figure 58. Germany Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 59. UK Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 60. France Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Russia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Italy Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions 2019
Figure 66. China Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Korea Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 69. India Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 71. South America Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2019
Figure 73. South America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2019
Figure 74. Brazil Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Egypt Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Turkey Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 83. South Africa Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Global Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2021-2025) (K MT)
Figure 85. Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025) (K MT)
Figure 87. Europe Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025) (K MT)
Figure 88. Asia-Pacific Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025) (K MT)
Figure 89. South America Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025) (K MT)
Figure 90. Middle East & Africa Sales Nuclear Medicine/Radiopharmaceutic Market Forecast (2021-2025) (K MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
600MHz核磁気共鳴分光計の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global 600 MHz Nuclear Magnetic Resonance Spectrometer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 137.1 million by 2025, from USD 118 milli…- 原子力電池の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Battery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nuclear Battery market report…
- 核磁気共鳴（NMR）分光計の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Magnetic Resonance (NMR) Spectrometer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1011 million by 2025, from USD 886.2 million in 201…
- 原子力蒸気発生器チューブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Nuclear Steam Generator Tubing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nuclear Steam …
- 原子炉の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Nuclear Reactor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -46.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1209.1 million by 2025, from USD 14770 million in 2019. The Nuclear Rea…